Cargando…
Balancing functions of annexin A6 maintain equilibrium between hypertrophy and apoptosis in cardiomyocytes
Pathological cardiac hypertrophy is a major risk factor associated with heart failure, a state concomitant with increased cell death. However, the mechanism governing progression of hypertrophy to apoptosis at the single-cell level remains elusive. Here, we demonstrate annexin A6 (Anxa6), a calcium...
Autores principales: | Banerjee, P, Chander, V, Bandyopadhyay, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650436/ https://www.ncbi.nlm.nih.gov/pubmed/26335715 http://dx.doi.org/10.1038/cddis.2015.231 |
Ejemplares similares
-
Interaction of annexin A6 with alpha actinin in cardiomyocytes
por: Mishra, Sumita, et al.
Publicado: (2011) -
Pioglitazone Induces Cardiomyocyte Apoptosis and Inhibits
Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway
por: Zhong, Wenliang, et al.
Publicado: (2018) -
A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration
por: Raso, Andrea, et al.
Publicado: (2021) -
Effect of tanshinone IIA on cardiomyocyte hypertrophy and apoptosis in spontaneously hypertensive rats
por: JIANG, F.L., et al.
Publicado: (2013) -
Downregulation of PTEN Promotes Autophagy via Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in PPAR α(−/−) Mice
por: Kumari, Ritu, et al.
Publicado: (2022)